共 103 条
[1]
Hunter JM(2017)Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation Br J of Anaesth 119 i53-i62
[2]
Hristovska AM(2018)The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis Anaesthesia. 73 631-641
[3]
Duch P(2012)Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study BMJ. 345 f1460-968
[4]
Allingstrup M(2013)Neostigmine reversal doesn't improve postoperative respiratory safety BMJ. 346 959-37
[5]
Afshari A(2014)Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes Anesthesiology. 121 27-1213
[6]
Grosse-Sundrup M(2018)Neostigmine Administration after Spontaneous Recovery to a Train-of-Four Ratio of 0.9 to 1.0 Anesthesiology 128 1201-91
[7]
Henneman JP(2015)Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications Anesthesiology. 122 85-57
[8]
Sandberg WS(1991)Mechanisms of respiratory failure produced by neostigmine and diisopropyl fluorophosphate Eur J Pharmacol 195 49-15
[9]
Bateman BT(2015)Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium Eur J Anaesthesiol 32 8-129
[10]
Uribe JV(2017)Diaphragmatic and intercostal electromyographic activity during neostigmine, sugammadex and neostigmine-sugammadex-enhanced recovery after neuromuscular blockade: a randomised controlled volunteer study Eur J Anaesthesiol 34 115-429